[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"content-doc-dcio2d659b10":3},{"user":4,"document":8,"mainDocument":27,"columnUrl":29,"subscription":30,"footer":42,"text":80},{"isAuthenticated":5,"isAdmin":5,"displayName":6,"avatarUrl":6,"nid":6,"groupLevel":7},false,"",-10,{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":21,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"useContentVideo":5,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},"dcio2d659b10","辉瑞(PFE)Q3利润超预期、非新冠产品增加7%，上调全年业绩指引","\u002Fdoc\u002Fdcio2d659b10","col18178739ee","美股资讯","\u002Fcol\u002Fcol18178739ee","\u003Cp>\n\u003C\u002Fp>\u003Cp>\u003Cspan>美股投资网获悉，辉瑞(PFE)11月3日盘前公布2026财年第三季度(截至9月27日)财报。当季调整后摊薄每股收益0.87美元，同比持平，显著高于市场一致预期0.73美元;GAAP摊薄每股收益0.56美元，同比下降9%。当季总营收165.83亿美元，同比基本持平，其中产品收入132.55亿美元、联盟收入28.51亿美元(增长24%)、特许权收入4.77亿美元。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>营收结构呈现\"新老动能切换\"的鲜明特征。剔除新冠产品Comirnaty和Paxlovid后，当季营收运营口径增长7%;其中上市及并购产品(Launched and Acquired Products)营收运营口径大增32%，成为本季最大亮点。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>具体看，抗凝药Eliquis全球收入25.23亿美元，运营口径增长25%，主要由美国净价格提升(回扣减少及渠道结构改善)及全球需求增长驱动;ADC药物Padcev收入7.20亿美元，增长55%，受益于一线尿路上皮癌市场份额扩大;Vyndaqel家族(治疗转甲状腺素蛋白淀粉样变心肌病)收入17.73亿美元，增长12%;偏头痛药Nurtec收入5.47亿美元，增长33%;肺癌药Lorbrena收入3.87亿美元，增长43%。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>按业务板块看，肿瘤业务收入43.27亿美元(+10%)，其中Ibrance收入10.82亿美元(+2%)、Xtandi收入5.41亿美元(-6%)、Braftovi\u002FMektovi收入2.44亿美元(+21%);专科护理收入33.49亿美元(+7%);初级护理收入69.71亿美元(-9%)，主要受新冠及Prevnar疫苗拖累;医院与生物类似药收入16.35亿美元(+2%)。辉瑞CentreOne(合同生产)收入3.00亿美元(-13%)。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>下滑项方面，Paxlovid全球收入4.49亿美元，同比下降63%，主因美欧新冠感染率下降;Comirnaty收入8.08亿美元，下降29%;Prevnar家族(肺炎球菌疫苗)收入15.64亿美元，下降10%，受成人及儿童疫苗接种率下降和成人市场份额流失影响。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>董事长兼首席执行官Albert Bourla表示\"辉瑞又一个表现强劲的季度，商业动能与严谨的执行并举。我们的肥胖症项目持续推进，近期在肿瘤、免疫和疫苗领域的里程碑进一步彰显了管线的潜力。\"\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>新任首席财务官Cecile Guegan表示\"第三季度非新冠产品实现了7%的运营收入增长，上市及并购产品32%的增长尤其令我满意。\"\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>基于强劲的年初至今表现，辉瑞上调并收窄全年指引2026年营收指引从此前的605亿–625亿美元上调至620亿–640亿美元(中点上调15亿美元);调整后摊薄每股收益指引从2.80–3.00美元上调并收窄至2.95–3.05美元。该指引包含第三季度因引进并合作信达生物(Innovent Biologics)而产生的6.5亿美元一次性在研项目研发(IPR&D)费用，对每股收益带来约0.10美元的不利影响。公司预计全年资本配置上继续向股东派发股息，2026年不进行股票回购。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>最专业的美股资讯,推荐美股大数据 \u003Ca href=\"https:\u002F\u002FStockwe.com\u002F\">https:\u002F\u002FStockwe.com\u002F\u003C\u002Fa>\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>如何识别美股市场异常波动？美国机构主力资金买卖情况，出货和吸筹，使用美股投资网VIP会员，2008年成立于美国硅谷，由前纽约证券交易所分析师Ken创立，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化模型，建立了一个股市数据库 \u003Ca href=\"https:\u002F\u002FStockWe.com\u002F\">https:\u002F\u002FStockWe.com\u002F\u003C\u002Fa> 每天处理千万级股票数据：捕捉期权大单，实时主力资金流向、机构持仓变化、川普突发新闻，精准交易信号第一时间发到您手机APP！\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003C\u002Fp>","https:\u002F\u002Fwww.tradesmax.com\u002Fimages\u002Fa_Stock\u002FP\u002FPFE\u002FPFE.jpg","2026-11-03T17:11:59","2026.11.03","2026\u002F11\u002F03",39262,[22],"PFE","Article",0,"免费","success",{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":28,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"useContentVideo":5,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},[22],"\u002Fcol\u002Fstocknews",{"visible":5,"marketingHtml":31,"services":32,"recentDocuments":41},"\u003Cfigure class=\"image\">\u003Ca href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\" rel=\"noopener noreferrer\">\u003Cimg src=\"\u002Fimg\u002Fstockwewebfiles\u002Fweb-202408-stk\u002F1586109431mceclip0.jpg\">\u003C\u002Fa>\u003C\u002Ffigure>\u003Cdiv class=\"text-center\">\u003Ch2 class=\"card-title mx-auto\">\u003Cbr>\u003Ca rel=\"noopener noreferrer\" href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\">案例介绍：英伟达深度研究报告\u003C\u002Fa>\u003C\u002Fh2>\u003C\u002Fdiv>",[33,37],{"productId":34,"serviceName":35,"priceText":36},"prod_PPxdDdK87QaiLv","月付","$12.95美元",{"productId":38,"serviceName":39,"priceText":40},"prod_PPxeMs3bix1da5","年付","$149.00美元",[],{"links":43,"images":71,"summaryHtml":76,"aboutTitle":77,"aboutHtml":78,"copyrightHtml":79},[44,47,50,53,56,59,62,65,68],{"label":45,"url":46},"深度报告","\u002Fcol\u002FdepthReport",{"label":48,"url":49},"VIP会员","\u002Fvip",{"label":51,"url":52},"期权推荐","\u002FOption",{"label":54,"url":55},"低价暴涨股","\u002FPenny",{"label":57,"url":58},"AI智能体","\u002FAiAgent",{"label":60,"url":61},"常见问题","https:\u002F\u002Fstockwe.com\u002FFAQ",{"label":63,"url":64},"美股课程","\u002Fcol\u002Fvideos",{"label":66,"url":67},"免责声明","\u002Fdisclaimer",{"label":69,"url":70},"联系我们","\u002FContactUs",[72,73,74,75],"\u002Fimages\u002Ffooter\u002Ffooter-1-wechat.gif?v=20260930c","\u002Fimages\u002Ffooter\u002Ffooter-2-telegram.png?v=20260930c","\u002Fimages\u002Ffooter\u002Ffooter-3-whatsapp.png?v=20260930c","\u002Fimages\u002Ffooter\u002Ffooter-4-line.png?v=20260930c","邮箱: buy@TradesMax.com 美国电话 626-378-3637","公司介绍","\u003Cp class=\"MsoNormal\">美股大数据 \u003Ca href=\"https:\u002F\u002Fstockwe.com\" rel=\"noopener\">StockWe.com\u003C\u002Fa> 是一个美国领先的金融和美股信息大数据提供商，紧盯华尔街金融市场和行情，2008年成立于美国硅谷，创始人是前纽约证券交易所资深分析师Ken，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化交易模型，每天处理海量股票数据：挖掘潜力大牛股，捕捉期权异动大单，实时主力资金流向、机构持仓变化、川普突发新闻，美股买卖信号第一时间发到您手机APP。\u003C\u002Fp>","专业美股投资者都在这里",{"loading":81,"search":82,"searchPlaceholder":82,"hotContent":83,"draft":84,"noData":85,"searchNoData":86,"courseContent":87,"more":88,"buyNow":89,"subscribeNow":90,"encoding":91,"paidContent":92},"Loading...","搜索","热门内容","草稿","目前没有任何内容公布","当前检索内容没有数据","课程内容","更多","立即购买后观看","- 立即订阅 -","视频编码中...","付费内容"]